APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isotopes for Nuclear Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Isotopes for Nuclear Medicine Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchIsotopes for Nuclear Medicine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Isotopes for Nuclear Medicine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Isotopes for Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isotopes for Nuclear Medicine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Isotopes for Nuclear Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Isotopes for Nuclear Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Isotopes for Nuclear Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Isotopes for Nuclear Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Isotopes for Nuclear Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Isotopes for Nuclear Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Isotopes for Nuclear Medicine include Urenco, SHINE Medical, NTP Radioisotopes, Northwest Medical Isotopes, Medical Isotopes, ITM, CMR and Cambridge Isotope Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Isotopes for Nuclear Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Isotopes for Nuclear Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Isotopes for Nuclear Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Isotopes for Nuclear Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Isotopes for Nuclear Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Isotopes for Nuclear Medicine revenue, projected growth trends, production technology, application and end-user industry.

Isotopes for Nuclear Medicine Segment by Company

Urenco

SHINE Medical

NTP Radioisotopes

Northwest Medical Isotopes

Medical Isotopes

ITM

CMR

Cambridge Isotope Laboratories

Isotopes for Nuclear Medicine Segment by Type

Stable Isotope

Radioisotope

Isotopes for Nuclear Medicine Segment by Application

Hospital

Laboratory

Others

Isotopes for Nuclear Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isotopes for Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isotopes for Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isotopes for Nuclear Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Isotopes for Nuclear Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Isotopes for Nuclear Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isotopes for Nuclear Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Isotopes for Nuclear Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stable Isotope Major Player Table 3. Radioisotope Major Player Table 4. Global Isotopes for Nuclear Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Laboratory Major Player Table 7. Others Major Player Table 8. Isotopes for Nuclear Medicine Industry Trends Table 9. Isotopes for Nuclear Medicine Industry Drivers Table 10. Isotopes for Nuclear Medicine Industry Opportunities and Challenges Table 11. Isotopes for Nuclear Medicine Industry Restraints Table 12. Global Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Isotopes for Nuclear Medicine Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Isotopes for Nuclear Medicine Market Share by Region (2021-2026) Table 15. Global Isotopes for Nuclear Medicine Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Isotopes for Nuclear Medicine Market Share by Region (2027-2032) Table 17. Global Isotopes for Nuclear Medicine Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Isotopes for Nuclear Medicine Revenue Market Share by Players (2021-2026) Table 19. Global Isotopes for Nuclear Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Isotopes for Nuclear Medicine Key Players Headquarters & Area Served Table 21. Global Isotopes for Nuclear Medicine Players, Product Type & Application Table 22. Global Isotopes for Nuclear Medicine Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Isotopes for Nuclear Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Isotopes for Nuclear Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Isotopes for Nuclear Medicine Revenue Market Share by Type (2021-2026) Table 29. Global Isotopes for Nuclear Medicine Revenue Market Share by Type (2027-2032) Table 30. Global Isotopes for Nuclear Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Isotopes for Nuclear Medicine Revenue Market Share by Application (2021-2026) Table 34. Global Isotopes for Nuclear Medicine Revenue Market Share by Application (2027-2032) Table 35. Urenco Company Information Table 36. Urenco Business Overview Table 37. Urenco Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Urenco Isotopes for Nuclear Medicine Product Portfolio Table 39. Urenco Recent Development Table 40. SHINE Medical Company Information Table 41. SHINE Medical Business Overview Table 42. SHINE Medical Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. SHINE Medical Isotopes for Nuclear Medicine Product Portfolio Table 44. SHINE Medical Recent Development Table 45. NTP Radioisotopes Company Information Table 46. NTP Radioisotopes Business Overview Table 47. NTP Radioisotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio Table 49. NTP Radioisotopes Recent Development Table 50. Northwest Medical Isotopes Company Information Table 51. Northwest Medical Isotopes Business Overview Table 52. Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio Table 54. Northwest Medical Isotopes Recent Development Table 55. Medical Isotopes Company Information Table 56. Medical Isotopes Business Overview Table 57. Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio Table 59. Medical Isotopes Recent Development Table 60. ITM Company Information Table 61. ITM Business Overview Table 62. ITM Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ITM Isotopes for Nuclear Medicine Product Portfolio Table 64. ITM Recent Development Table 65. CMR Company Information Table 66. CMR Business Overview Table 67. CMR Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CMR Isotopes for Nuclear Medicine Product Portfolio Table 69. CMR Recent Development Table 70. Cambridge Isotope Laboratories Company Information Table 71. Cambridge Isotope Laboratories Business Overview Table 72. Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio Table 74. Cambridge Isotope Laboratories Recent Development Table 75. North America Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Isotopes for Nuclear Medicine Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Isotopes for Nuclear Medicine Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Isotopes for Nuclear Medicine Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Isotopes for Nuclear Medicine Revenue by Country (US$ Million) & (2027-2032) Table 89. China Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 90. China Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 91. China Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 92. China Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Isotopes for Nuclear Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Isotopes for Nuclear Medicine Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Isotopes for Nuclear Medicine Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Isotopes for Nuclear Medicine Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Isotopes for Nuclear Medicine Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Isotopes for Nuclear Medicine Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Isotopes for Nuclear Medicine Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Isotopes for Nuclear Medicine Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Isotopes for Nuclear Medicine Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Isotopes for Nuclear Medicine Image Figure 2. Global Isotopes for Nuclear Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isotopes for Nuclear Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stable Isotope Image Figure 5. Radioisotope Image Figure 6. Global Isotopes for Nuclear Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Isotopes for Nuclear Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Laboratory Image Figure 10. Others Image Figure 11. Global Isotopes for Nuclear Medicine Market Size (US$ Million) & (2021-2032) Figure 12. Global Isotopes for Nuclear Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Isotopes for Nuclear Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Isotopes for Nuclear Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Isotopes for Nuclear Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Isotopes for Nuclear Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Isotopes for Nuclear Medicine Revenue Market Share by Type (2021-2032) Figure 19. Global Isotopes for Nuclear Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Isotopes for Nuclear Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Isotopes for Nuclear Medicine Revenue Market Share by Application (2021-2032) Figure 22. North America Isotopes for Nuclear Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032) Figure 24. North America Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032) Figure 25. North America Isotopes for Nuclear Medicine Revenue Share by Country (2021-2032) Figure 26. United States Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Isotopes for Nuclear Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032) Figure 31. Europe Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032) Figure 32. Europe Isotopes for Nuclear Medicine Revenue Share by Country (2021-2032) Figure 33. Germany Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Isotopes for Nuclear Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032) Figure 43. China Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032) Figure 44. Asia Isotopes for Nuclear Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032) Figure 46. Asia Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032) Figure 47. Asia Isotopes for Nuclear Medicine Revenue Share by Region (2021-2032) Figure 48. Japan Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Isotopes for Nuclear Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032) Figure 56. SAMEA Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032) Figure 57. SAMEA Isotopes for Nuclear Medicine Revenue Share by Country (2021-2032) Figure 58. Brazil Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Isotopes for Nuclear Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Urenco
  • SHINE Medical
  • NTP Radioisotopes
  • Northwest Medical Isotopes
  • Medical Isotopes
  • ITM
  • CMR
  • Cambridge Isotope Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Isotopes for Nuclear Medicine Market by Type
  3. 1.2.1 Global Isotopes for Nuclear Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stable Isotope
  5. 1.2.3 Radioisotope
  6. 1.3 Isotopes for Nuclear Medicine Market by Application
  7. 1.3.1 Global Isotopes for Nuclear Medicine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Laboratory
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Isotopes for Nuclear Medicine Market Dynamics
  1. 2.1 Isotopes for Nuclear Medicine Industry Trends
  2. 2.2 Isotopes for Nuclear Medicine Industry Drivers
  3. 2.3 Isotopes for Nuclear Medicine Industry Opportunities and Challenges
  4. 2.4 Isotopes for Nuclear Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Isotopes for Nuclear Medicine Market Perspective (2021-2032)
  2. 3.2 Global Isotopes for Nuclear Medicine Growth Trends by Region
  3. 3.2.1 Global Isotopes for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Isotopes for Nuclear Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Isotopes for Nuclear Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Isotopes for Nuclear Medicine Revenue by Players
  2. 4.1.1 Global Isotopes for Nuclear Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Isotopes for Nuclear Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Isotopes for Nuclear Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Isotopes for Nuclear Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Isotopes for Nuclear Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Isotopes for Nuclear Medicine Players, Product Type & Application
  8. 4.5 Global Isotopes for Nuclear Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Isotopes for Nuclear Medicine Market CR5 and HHI
  11. 4.6.3 2025 Isotopes for Nuclear Medicine Tier 1, Tier 2, and Tier 3
5 Isotopes for Nuclear Medicine Market Size by Type
  1. 5.1 Global Isotopes for Nuclear Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Isotopes for Nuclear Medicine Revenue Market Share by Type (2021-2032)
6 Isotopes for Nuclear Medicine Market Size by Application
  1. 6.1 Global Isotopes for Nuclear Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Isotopes for Nuclear Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Urenco
  2. 7.1.1 Urenco Company Information
  3. 7.1.2 Urenco Business Overview
  4. 7.1.3 Urenco Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Urenco Isotopes for Nuclear Medicine Product Portfolio
  6. 7.1.5 Urenco Recent Developments
  7. 7.2 SHINE Medical
  8. 7.2.1 SHINE Medical Company Information
  9. 7.2.2 SHINE Medical Business Overview
  10. 7.2.3 SHINE Medical Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SHINE Medical Isotopes for Nuclear Medicine Product Portfolio
  12. 7.2.5 SHINE Medical Recent Developments
  13. 7.3 NTP Radioisotopes
  14. 7.3.1 NTP Radioisotopes Company Information
  15. 7.3.2 NTP Radioisotopes Business Overview
  16. 7.3.3 NTP Radioisotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio
  18. 7.3.5 NTP Radioisotopes Recent Developments
  19. 7.4 Northwest Medical Isotopes
  20. 7.4.1 Northwest Medical Isotopes Company Information
  21. 7.4.2 Northwest Medical Isotopes Business Overview
  22. 7.4.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
  24. 7.4.5 Northwest Medical Isotopes Recent Developments
  25. 7.5 Medical Isotopes
  26. 7.5.1 Medical Isotopes Company Information
  27. 7.5.2 Medical Isotopes Business Overview
  28. 7.5.3 Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
  30. 7.5.5 Medical Isotopes Recent Developments
  31. 7.6 ITM
  32. 7.6.1 ITM Company Information
  33. 7.6.2 ITM Business Overview
  34. 7.6.3 ITM Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ITM Isotopes for Nuclear Medicine Product Portfolio
  36. 7.6.5 ITM Recent Developments
  37. 7.7 CMR
  38. 7.7.1 CMR Company Information
  39. 7.7.2 CMR Business Overview
  40. 7.7.3 CMR Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CMR Isotopes for Nuclear Medicine Product Portfolio
  42. 7.7.5 CMR Recent Developments
  43. 7.8 Cambridge Isotope Laboratories
  44. 7.8.1 Cambridge Isotope Laboratories Company Information
  45. 7.8.2 Cambridge Isotope Laboratories Business Overview
  46. 7.8.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio
  48. 7.8.5 Cambridge Isotope Laboratories Recent Developments
8 North America
  1. 8.1 North America Isotopes for Nuclear Medicine Revenue (2021-2032)
  2. 8.2 North America Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Isotopes for Nuclear Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Isotopes for Nuclear Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Isotopes for Nuclear Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Isotopes for Nuclear Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Isotopes for Nuclear Medicine Revenue by Country
  11. 8.6.1 North America Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Isotopes for Nuclear Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Isotopes for Nuclear Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Isotopes for Nuclear Medicine Revenue (2021-2032)
  2. 9.2 Europe Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Isotopes for Nuclear Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Isotopes for Nuclear Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Isotopes for Nuclear Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Isotopes for Nuclear Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Isotopes for Nuclear Medicine Revenue by Country
  11. 9.6.1 Europe Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Isotopes for Nuclear Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Isotopes for Nuclear Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Isotopes for Nuclear Medicine Revenue (2021-2032)
  2. 10.2 China Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Isotopes for Nuclear Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Isotopes for Nuclear Medicine Revenue by Type (2027-2032)
  5. 10.3 China Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Isotopes for Nuclear Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Isotopes for Nuclear Medicine Revenue by Application (2027-2032)
  9. 10.5 China Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Isotopes for Nuclear Medicine Revenue (2021-2032)
  2. 11.2 Asia Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Isotopes for Nuclear Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Isotopes for Nuclear Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Isotopes for Nuclear Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Isotopes for Nuclear Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Isotopes for Nuclear Medicine Revenue by Country
  11. 11.6.1 Asia Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Isotopes for Nuclear Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Isotopes for Nuclear Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Isotopes for Nuclear Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Isotopes for Nuclear Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Isotopes for Nuclear Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Isotopes for Nuclear Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Isotopes for Nuclear Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Isotopes for Nuclear Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Isotopes for Nuclear Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Isotopes for Nuclear Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Isotopes for Nuclear Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Isotopes for Nuclear Medicine Revenue by Country
  11. 12.6.1 SAMEA Isotopes for Nuclear Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Isotopes for Nuclear Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Isotopes for Nuclear Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst